Benzinga | Jul 28, 2021 06:18AM EDT

Integra Lifesciences Q2 EPS $0.79 Beats $0.66 Estimate, Sales $389.99M Beat $376.01M Estimate

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.66 by 19.7 percent. This is a 139.39 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $389.99 million which beat the analyst consensus estimate of $376.01 million by 3.72 percent. This is a 50.77 percent increase over sales of $258.67 million the same period last year.